Invesco Ltd (NYSE: IVZ)’s stock price has gone rise by 0.80 in comparison to its previous close of 17.48, however, the company has experienced a -4.76% decrease in its stock price over the last five trading days. prnewswire.com reported 2025-02-20 that ATLANTA, Feb. 20, 2025 /PRNewswire/ — Invesco Mortgage Capital Inc. (NYSE: IVR) (the “Company”) today announced financial results for the quarter ended December 31, 2024. Net loss per common share of $0.09 compared to net income of $0.63 in Q3 2024 Earnings available for distribution per common share(1) of $0.53 compared to $0.68 in Q3 2024 Common stock dividend of $0.40 per common share, unchanged from Q3 2024 Book value per common share(2) of $8.92 compared to $9.37 as of September 30, 2024 Economic return(3) of (0.5)% compared to 5.4% in Q3 2024 Improved capital structure through redemption of Series B Preferred Stock Update from John Anzalone, Chief Executive Officer “Long-term Treasury yields rose sharply during the fourth quarter as the disinflationary trend stalled and market participants recalibrated their expectations for future monetary and fiscal policy.
Is It Worth Investing in Invesco Ltd (NYSE: IVZ) Right Now?
Invesco Ltd (NYSE: IVZ) has a price-to-earnings ratio that is above its average at 14.90x. The stock has a 36-month beta value of 1.40. Opinions on the stock are mixed, with 2 analysts rating it as a “buy,” 0 as “overweight,” 14 as “hold,” and 1 as “sell.”
The public float for IVZ is 441.76M, and at present, short sellers hold a 2.70% of that float. On February 25, 2025, the average trading volume of IVZ was 3.70M shares.
IVZ’s Market Performance
The stock of Invesco Ltd (IVZ) has seen a -4.76% decrease in the past week, with a 0.23% rise in the past month, and a 2.03% gain in the past quarter. The volatility ratio for the week is 2.61%, and the volatility levels for the past 30 days are at 2.54% for IVZ. The simple moving average for the last 20 days is -4.86% for IVZ’s stock, with a simple moving average of 4.06% for the last 200 days.
Analysts’ Opinion of IVZ
Many brokerage firms have already submitted their reports for IVZ stocks, with Wells Fargo repeating the rating for IVZ by listing it as a “Underweight.” The predicted price for IVZ in the upcoming period, according to Wells Fargo is $16 based on the research report published on September 12, 2024 of the previous year 2024.
Barclays, on the other hand, stated in their research note that they expect to see IVZ reach a price target of $18. The rating they have provided for IVZ stocks is “Equal Weight” according to the report published on August 27th, 2024.
TD Cowen gave a rating of “Outperform” to IVZ, setting the target price at $21 in the report published on January 04th of the previous year.
IVZ Trading at -1.45% from the 50-Day Moving Average
After a stumble in the market that brought IVZ to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -9.87% of loss for the given period.
Volatility was left at 2.54%, however, over the last 30 days, the volatility rate increased by 2.61%, as shares sank -0.06% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -4.03% lower at present.
During the last 5 trading sessions, IVZ fell by -4.76%, which changed the moving average for the period of 200-days by +17.86% in comparison to the 20-day moving average, which settled at $18.52. In addition, Invesco Ltd saw 0.80% in overturn over a single year, with a tendency to cut further gains.
Stock Fundamentals for IVZ
Current profitability levels for the company are sitting at:
- -0.09 for the present operating margin
- 0.45 for the gross margin
The net margin for Invesco Ltd stands at -0.04. The total capital return value is set at -0.02. Equity return is now at value 5.31, with 2.77 for asset returns.
Currently, EBITDA for the company is 832.1 million with net debt to EBITDA at -1.04. When we switch over and look at the enterprise to sales, we see a ratio of 1.18.
Conclusion
To sum up, Invesco Ltd (IVZ) has seen a better performance recently. Analysts have differing views on the stock, with some seeing it as a “buy” and others as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
